ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639514 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639514; 2) Community: the network communities that were significantly associated with the response to NSC 639514; 3) Molecule: the relationships between components within communities and NSC 639514; 4) MDR: the compounds that were significantly associated with the NSC 639514.

NSC Compound Enrichment Correlation
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0378615809326463 0.54467078
NSC 244404 Null 0.0378615809326463 0.29216281
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0378615809326463 0.43848657
NSC 303861 L-Cysteine analog 0.0378615809326463 0.58846372
NSC 33570 Null 0.0378615809326463 0.52182037
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0378615809326463 0.11335693
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0378615809326463 0.19326225
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0378615809326463 0.23118934
NSC 409749 Null 0.0378615809326463 0.37747922
NSC 45236 Null 0.0378615809326463 0.23289231
Total:114  Current:91    [First] [Prev] [Next] [Last]